The Justice Department announced a resolution with the Cleveland Clinic Foundation on June 6, 2026, requiring the hospital system to cease providing gender-transition interventions to minors and to pay $308,000 to resolve allegations that it submitted false billings to public and private payors [1]. Cleveland Clinic denied all allegations underlying the agreement [1][2].
The settlement rests on False Claims Act authority, which exposes healthcare providers to civil liability for submitting fraudulent claims to federal programs such as Medicaid and Medicare [1]. DOJ coordinated the resolution with Ohio Attorney General Dave Yost, whose office pursued parallel state-law theories [1][2]. Deputy Attorney General Todd Blanche was identified as a principal figure in DOJ's enforcement posture on the issue [1]. The agreement requires Cleveland Clinic to permanently discontinue gender-transition procedures, including puberty-blocking medications and surgical interventions, for patients under 18 [1][2].
The Cleveland Clinic settlement is the second major agreement in DOJ's declared national enforcement campaign targeting pediatric gender-affirming care. The first involved Texas Children's Hospital, resolved in May 2026 [1]. DOJ has characterized the campaign as ongoing, signaling that additional hospitals remain under investigation [1]. The coordinated federal-state structure of the Cleveland Clinic deal, combining DOJ's False Claims Act claims with the Ohio attorney general's involvement, reflects an enforcement model that the department appears to be replicating across jurisdictions [1][2].
No litigation schedule has been publicly filed, as the matter was resolved short of formal complaint. DOJ's pattern of announcements suggests further resolutions with other hospital systems may follow in the coming months [1].